Defining the invasive biology of clinically relevant LKB1 mutations in lung cancer.

被引：0
|
作者：
Commander, R. [1 ]
Hou, Y. [2 ]
Konen, J. [1 ]
Wilkinson, S. [1 ]
Gilbert-Ross, M. [3 ]
Cooper, L. [2 ]
Marcus, A. I. [3 ]
机构：
[1] Emory Univ, Canc Biol, Atlanta, GA 30322 USA
[2] Emory Univ, Biomed Informat, Atlanta, GA 30322 USA
[3] Emory Univ, Hematol & Med Oncol, Atlanta, GA 30322 USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P312
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations
    Fernandez, P
    Carretero, J
    Medina, PP
    Jimenez, AI
    Rodriguez-Perales, S
    Paz, MF
    Cigudosa, JC
    Esteller, M
    Lombardia, L
    Morente, M
    Sanchez-Verde, L
    Sotelo, T
    Sanchez-Cespedes, M
    ONCOGENE, 2004, 23 (29) : 5084 - 5091
  • [22] Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations
    Paloma Fernandez
    Julian Carretero
    Pedro P Medina
    Ana I Jimenez
    Sandra Rodriguez-Perales
    Maria F Paz
    Juan C Cigudosa
    Manel Esteller
    Luis Lombardia
    Manuel Morente
    Lydia Sanchez-Verde
    Teresa Sotelo
    Montserrat Sanchez-Cespedes
    Oncogene, 2004, 23 : 5084 - 5091
  • [23] Dysregulation of lung developmental pathways associated with LKB1 loss in lung cancer
    Kaufman, Jacob M.
    Lowe, Cindy
    Harris, Bradford
    Boyd, Kelli
    Amann, Joseph
    Eisenberg, Rosana
    Carbone, David
    Massion, Pierre
    CANCER RESEARCH, 2016, 76
  • [24] LKB1 expression and the prognosis of lung cancer A meta-analysis
    Lin, Chunxuan
    Lin, Xiaochun
    Lin, Kunpeng
    Tan, Jialiang
    Wei, Chenggong
    Liu, Taisheng
    MEDICINE, 2021, 100 (46) : E27841
  • [25] Simvastatin is synthetically lethal to the loss of LKB1 in lung cancer cells
    Helbling, Marianne M.
    Schmitt, Iris
    Greiner, Erich
    Krek, Wilhelm
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [26] Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients
    Koivunen, J. P.
    Kim, J.
    Lee, J.
    Rogers, A. M.
    Park, J. O.
    Zhao, X.
    Naoki, K.
    Okamoto, I.
    Nakagawa, K.
    Yeap, B. Y.
    Meyerson, M.
    Wong, K-K
    Richards, W. G.
    Sugarbaker, D. J.
    Johnson, B. E.
    Jaenne, P. A.
    BRITISH JOURNAL OF CANCER, 2008, 99 (02) : 245 - 252
  • [27] A Novel Tumor Suppressor LKB1 in Lung Cancer Differentiation and Metastasis
    Hongbin JI Institute of Biochemistry and Cell Biology Shanghai Institutes of Biological Sciences Chinese Academy of Sciences Shanghai China
    中国肺癌杂志, 2009, 12 (06) : 16 - 16
  • [28] STK11/LKB1 Modulation of the Immune Response in Lung Cancer: From Biology to Therapeutic Impact
    Pons-Tostivint, Elvire
    Lugat, Alexandre
    Fontenau, Jean-Francois
    Denis, Marc Guillaume
    Bennouna, Jaafar
    CELLS, 2021, 10 (11)
  • [29] Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients
    J P Koivunen
    J Kim
    J Lee
    A M Rogers
    J O Park
    X Zhao
    K Naoki
    I Okamoto
    K Nakagawa
    B Y Yeap
    M Meyerson
    K-K Wong
    W G Richards
    D J Sugarbaker
    B E Johnson
    P A Jänne
    British Journal of Cancer, 2008, 99 : 245 - 252
  • [30] Targeting LKB1 signaling in cancer
    Korsse, S. E.
    Peppelenbosch, M. P.
    van Veelen, W.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2013, 1835 (02): : 194 - 210
12345